Loading…
Based on limited metadata, this warning letter was issued to ACRX Specialty Pharmacy Inc., a pharmacy operation, on July 24, 2020, regarding drug products and pharmacy practices. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available metadata. The FDA's Drug division issued this warning, indicating the violations relate to pharmaceutical drug handling, distribution, or compounding operations. Additional documentation would be needed to identify the specific regulatory violations cited.